Canopy Growth Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Canopy Growth wird ein jährliches Gewinn- und Umsatzwachstum von 54.9% bzw. 11.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 56.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -221.8% betragen.

Wichtige Informationen

68.7%

Wachstumsrate der Gewinne

74.4%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	50.3%
Wachstumsrate der Einnahmen	7.1%
Zukünftige Eigenkapitalrendite	-22.0%
Analystenabdeckung	Good
Zuletzt aktualisiert	30 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report

Feb 13

Recent updates

More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 26%

Aug 28

We Think Canopy Growth (TSE:WEED) Has A Fair Chunk Of Debt

Aug 17

Some Confidence Is Lacking In Canopy Growth Corporation (TSE:WEED) As Shares Slide 26%

Jun 15

Canopy Growth Corporation's (TSE:WEED) 77% Share Price Surge Not Quite Adding Up

Apr 20

More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 28%

Feb 23

Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report

Feb 13

Why We're Not Concerned Yet About Canopy Growth Corporation's (TSE:WEED) 42% Share Price Plunge

Dec 22

Is Canopy Growth (TSE:WEED) A Risky Investment?

Sep 17

With A 31% Price Drop For Canopy Growth Corporation (TSE:WEED) You'll Still Get What You Pay For

Apr 17

Is Canopy Growth (TSE:WEED) Using Too Much Debt?

Mar 21

Earnings Update: Canopy Growth Corporation (TSE:WEED) Just Reported And Analysts Are Trimming Their Forecasts

Feb 12

Is Canopy Growth (TSE:WEED) Using Too Much Debt?

Dec 08

Gewinn- und Umsatzwachstumsprognosen

TSX:WEED - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CAD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2027	349	-80	-59	-75	3
3/31/2026	315	-105	-78	-91	8
3/31/2025	286	-188	-130	-101	11
6/30/2024	287	-602	-191	-185	N/A
3/31/2024	297	-484	-286	-282	N/A
12/31/2023	293	-984	-407	-400	N/A
9/30/2023	299	-976	-520	-511	N/A
6/30/2023	317	-1,025	-576	-566	N/A
3/31/2023	333	-3,079	-568	-558	N/A
12/31/2022	367	-3,051	-559	-544	N/A
9/30/2022	423	-2,938	-583	-568	N/A
6/30/2022	466	-2,766	-550	-521	N/A
3/31/2022	476	-255	-594	-546	N/A
12/31/2021	557	-428	-587	-517	N/A
9/30/2021	569	-1,223	-552	-437	N/A
6/30/2021	572	-1,244	-644	-513	N/A
3/31/2021	547	-1,745	-622	-466	N/A
12/31/2020	506	-2,348	-803	-579	N/A
9/30/2020	477	-1,535	-1,033	-681	N/A
6/30/2020	419	-1,244	-1,282	-733	N/A
3/31/2020	399	-1,321	-1,495	-773	N/A
12/31/2019	385	-415	-1,610	-802	N/A
9/30/2019	344	-256	-1,578	-709	N/A
6/30/2019	291	-832	-1,408	-626	N/A
3/31/2019	226	-736	-1,254	-535	N/A
12/31/2018	155	-398	-958	-332	N/A
9/30/2018	94	-464	-709	-257	N/A
6/30/2018	88	-148	-462	-137	N/A
3/31/2018	78	-67	N/A	-82	N/A
12/31/2017	70	-21	N/A	-60	N/A
9/30/2017	58	-19	N/A	-41	N/A
6/30/2017	49	-13	N/A	-36	N/A
3/31/2017	40	-8	N/A	-27	N/A
12/31/2016	30	-1	N/A	-14	N/A
9/30/2016	24	-7	N/A	-15	N/A
6/30/2016	18	-8	N/A	-14	N/A
3/31/2016	13	-3	N/A	-14	N/A
12/31/2015	8	0	N/A	-14	N/A
9/30/2015	6	1	N/A	-12	N/A
6/30/2015	3	-5	N/A	-10	N/A
3/31/2015	2	-7	N/A	-9	N/A
12/31/2014	1	-9	N/A	-10	N/A
9/30/2014	1	-7	N/A	-8	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: WEED wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: WEED wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: WEED wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: WEEDDie Einnahmen des Unternehmens (11.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (6.6% pro Jahr).

Hohe Wachstumseinnahmen: WEEDDie Einnahmen des Unternehmens (11.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: WEED wird voraussichtlich in 3 Jahren unrentabel sein.

Canopy Growth Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 42%

Consensus EPS estimates fall by 15%

Price target increased by 21% to CA$7.73

Price target increased by 19% to CA$6.39

Price target decreased by 22% to CA$5.39

Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report

Recent updates

More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 26%

Insider recently sold CA$140k worth of stock

We Think Canopy Growth (TSE:WEED) Has A Fair Chunk Of Debt

David Klein Announces to Retire as CEO of Canopy Growth Corporation

Consensus EPS estimates fall by 42%

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Canopy Growth Corporation to Report Q2, 2025 Results on Nov 12, 2024

Canopy Growth Corporation to Report Q1, 2025 Results on Aug 09, 2024

Canopy Growth Corporation, Annual General Meeting, Sep 24, 2024

Now 23% undervalued after recent price drop

Consensus EPS estimates fall by 15%

Some Confidence Is Lacking In Canopy Growth Corporation (TSE:WEED) As Shares Slide 26%

Canopy Growth Corporation has filed a Follow-on Equity Offering in the amount of $250 million.

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Canopy Growth Corporation to Report Q4, 2024 Results on May 30, 2024

New major risk - Shareholder dilution

Canopy Growth Corporation (TSX:WEED) exercised its option to acquire Wana Brands for $300 million.

Price target increased by 21% to CA$7.73

Less than half of directors are independent

Canopy Growth Corporation's (TSE:WEED) 77% Share Price Surge Not Quite Adding Up

Canopy Growth Corporation Announces Board and Committee Changes

Price target increased by 19% to CA$6.39

Price target decreased by 22% to CA$5.39

More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 28%

Canopy Growth Launches New Pre-Rolls from 7Acres and Hiway

Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report

Price target decreased by 17% to CA$7.29

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Canopy Growth Corporation Announces Board Changes

New major risk - Revenue and earnings growth

Bioriginal Food & Science Corporation acquired KeyLeaf Life Sciences from Canopy Growth Corporation (TSX:WEED).

Canopy Growth Corporation Announces the Introduction of New Product Offerings Across the Company's Adult Use and Medical Cannabis Portfolio

Canopy Growth Corporation announced that it expects to receive $35.000008 million in funding

Canopy Growth Corporation to Report Q3, 2024 Results on Feb 09, 2024

Canopy Growth Corporation announced that it expects to receive $30 million in funding

Why We're Not Concerned Yet About Canopy Growth Corporation's (TSE:WEED) 42% Share Price Plunge

Inspirit Management Ltd acquired This Works Products Limited from Canopy Growth Corporation (TSX:WEED) for £9.3 million.

Price target increased by 9.3% to CA$0.95

Canopy Growth Corporation Partners with Marquee Brands Partners and Martha Stewart CBD to Unveil New Line of Need-Based CBD Gummies

Canopy Growth Corporation Announces the Addition of Four New Flower Product Offerings from Iconic Brands 7ACRES and Tweed

New major risk - Financial position

Price target decreased by 10% to CA$0.94

New minor risk - Insider selling

Insufficient new directors

Price target increased by 14% to CA$0.98

Canopy Growth Corporation announced that it expects to receive $24.99312 million in funding

Canopy Growth Corporation announced that it expects to receive $24.99312 million in funding

Is Canopy Growth (TSE:WEED) A Risky Investment?

Consensus EPS estimates upgraded to CA$0.43 loss, revenue downgraded

Price target decreased by 57% to CA$0.86

Canopy Growth Corporation Announces Addition of Five New Pre-Roll Flower Product Offerings from Iconic Brands Tweed, 7ACRES, and for the First Time, from Spectrum Therapeutics

Canopy Growth Corporation Announces Executive Changes

Canopy Growth Receives Written Notice from Nasdaq Regarding Minimum Bid Price Requirement

Canopy Growth Corporation, Annual General Meeting, Sep 25, 2023

Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuit on Behalf of the Investors in Canopy Growth Corporation Who Suffered Losses from Purchasing or Otherwise Acquiring Canopy Securities Between June 1, 2021 and May 10, 2023

An unknown buyer acquired a Facility in Modesto, CA from Canopy Growth Corporation (TSX:WEED).

Canopy Growth Corporation to Report Q4, 2023 Results on Jun 22, 2023

Canopy Growth Corporation announced delayed amended 10-K filing

Canopy Growth Corporation announced delayed annual 10-K filing

Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Canopy Growth Corporation

With A 31% Price Drop For Canopy Growth Corporation (TSE:WEED) You'll Still Get What You Pay For

Is Canopy Growth (TSE:WEED) Using Too Much Debt?

Earnings Update: Canopy Growth Corporation (TSE:WEED) Just Reported And Analysts Are Trimming Their Forecasts

Price target decreased by 10% to CA$4.37

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

420 Investments Ltd. acquired Five Retail Locations in Alberta from Canopy Growth Corporation (TSX:WEED).

Is Canopy Growth (TSE:WEED) Using Too Much Debt?

Canopy Growth Corporation Announces Termination of Julious Grant as Chief Commercial Officer, Effective December 16, 2022

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind